World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
23353
World Ranking
19581
National Ranking
9750

Sunder Mudaliar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sunder Mudaliar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 190 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sunder Mudaliar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sunder Mudaliar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sunder Mudaliar is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with an emphasis on endocrinology, diabetes, and metabolism. They have contributed 41 publications in the field of medicine, specifically including 13 works in endocrinology, diabetes, and metabolism. Other subfields covered in their research include physiology, molecular biology, epidemiology, and genetics.

The scientist's main research topics center on diabetes treatment and management, diabetes management and research, and metabolism related to diabetes and cancer. Additional areas of study include diet and metabolism, dementia and cognitive impairment research, pharmacology and obesity treatment, as well as adipokines, inflammation, and metabolic diseases.

Among recent papers authored or co-authored by Mudaliar are:

  • "Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice" (2022, Diabetes Obesity and Metabolism)
  • "Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia" (2023, Diabetes Obesity and Metabolism)
  • "SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis" (2021, The Journal of Clinical Endocrinology & Metabolism)
  • "Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad" (2020, Current Diabetes Reports)
  • "Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes" (2023, JAMA Internal Medicine)

Frequent co-authors working with Mudaliar include:

  • Margaret Tiktin
  • Heidi Krause-Steinrauf
  • Silvio E. Inzucchi
  • Elizabeth Burgess
  • Darin E. Olson

The scientist's articles appear in several notable publication venues with multiple contributions in some journals. These include:

  • Diabetes Care (4 publications)
  • Diabetes Obesity and Metabolism (2 publications)
  • Circulation
  • The Journal of Clinical Endocrinology & Metabolism
  • Current Diabetes Reports

Best Publications

  • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

    Jerzy W Kolaczynski;Mark R Nyce;Robert V Considine;Guenther Boden

  • Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Frank L Greenway;Ken Fujioka;Raymond A Plodkowski;Sunder Mudaliar

  • Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

    Sunder Mudaliar;Robert R. Henry;Arun J. Sanyal;Linda Morrow

  • Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

    Ralph A. DeFronzo;Devjit Tripathy;Dawn C. Schwenke;Dawn C. Schwenke;Mary Ann Banerji

  • Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis

    Sunder Mudaliar;Sindura Alloju;Robert R Henry

  • Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study

    George A. Bray;Sharon L. Edelstein;Jill P. Crandall;Vanita R. Aroda

  • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    S E Nikoulina;T P Ciaraldi;S Mudaliar;P Mohideen

  • Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Philip Raskin;Bruce W. Bode;Jennifer B. Marks;Irl B. Hirsch

  • New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.

    Sunder Mudaliar;Robert R. Henry

  • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

    S R Mudaliar;F A Lindberg;M Joyce;P Beerdsen

  • Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion: Results of a randomized, placebo-controlled study

    David Polidori;Sue Sha;Sunder Mudaliar;Theodore P. Ciaraldi

  • Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy

    Susan A. Phillips;Theodore P. Ciaraldi;Alice P.S. Kong;Rahil Bandukwala

  • Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers.

    Robert R. Henry;Theodore P. Ciaraldi;Theodore P. Ciaraldi;Debra Armstrong;Paivi Burke

  • Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study

    Robert R Henry;A Michael Lincoff;Sunder Mudaliar;Michael Rabbia

  • Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise.

    R. S. Richardson;H. Wagner;S. R. D. Mudaliar;R. Henry

  • Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

    Robert R Henry;Julio Rosenstock;Steven Edelman;Sunder Mudaliar

  • Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications

    Sunder Mudaliar;Anna R Chang;Robert R Henry

  • Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

    Neelima V. Chu;Alice P. S. Kong;Dennis D. Kim;Debra Armstrong

  • Insulin therapy in type 2 diabetes.

    Sunder Mudaliar;Steven V. Edelman;Steven V. Edelman

  • Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary

    David Polidori;Sue Sha;Sunder Mudaliar;Theodore P. Ciaraldi

Frequent Co-Authors

Robert R. Henry
Robert R. Henry University of California, San Diego
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
George A. Bray
George A. Bray Louisiana State University
Thomas A. Buchanan
Thomas A. Buchanan University of Southern California
Robert E. Ratner
Robert E. Ratner Georgetown University
Abbas E. Kitabchi
Abbas E. Kitabchi University of Tennessee Health Science Center
Dilip V. Jeste
Dilip V. Jeste University of California, San Diego
Paul Clopton
Paul Clopton Stanford University
Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Philip A. Kern
Philip A. Kern University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in exploring medical careers beyond an MD? There are a variety of online bachelor's in nutrition programs that prepare students for roles in wellness, health promotion, and dietetics. These degrees combine science with practical skills for those who want to have a direct impact on health outside traditional medicine.

For those aiming for healthcare leadership, best online mha programs offer a flexible pathway to working in hospital administration, healthcare policy, or management roles within medical organizations.

Nursing professionals looking to advance can benefit from the rn to bsn online no clinicals accredited programs, which deliver advanced nursing education without traditional hands-on clinical requirements—ideal for working RNs.

If your goal is to reach the highest clinical level, consider the shortest dnp programs online. These options allow qualified nurses to earn a Doctor of Nursing Practice and open doors to leadership, advocacy, and advanced patient care, all in a streamlined format.

These online healthcare degrees can create diverse pathways—both clinical and non-clinical—to impactful medical and health-related careers in the USA.

Best Scientists Citing Sunder Mudaliar

Trending Scientists